Current role
William Forbes
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About William Forbes
The proxy statement of Trevi Therapeutics, Inc. reports total compensation of $1,180,794 for William Forbes in fiscal 2021, including a base salary of $406,731.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Trevi Therapeutics, Inc. (TRVI)
Transcript header (unverified)
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Trevi Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Galletta Chief Accounting Officer
- Anne VanLent Board Member
- Dominick C. Colangelo Board Member
- James V. Cassella Board Member
- Jennifer Good Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Trevi Therapeutics, Inc. (TRVI) | Pharm. D. Chief Development Officer | $406,731 | $1,180,794 |
Recent activity
No call appearances or filed executive changes recorded yet.